Anlon Healthcare Ltd vs Archit Organosys Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Mar 23, 2026

Key Highlights

The Latest Trading Price of Anlon Healthcare Ltd is ₹ 121.35 as of 20 Mar 15:30 . The P/E Ratio of Anlon Healthcare Ltd is 0 as of March 2023 .The P/E Ratio of Archit Organosys Ltd is 10.9 as of March 2023 . The Market Cap of Anlon Healthcare Ltd is ₹ 0 crore as of March 2023 .The Market Cap of Archit Organosys Ltd is ₹ 123.92 crore as of March 2023 . The revenue of Anlon Healthcare Ltd for the Dec '25 is ₹ 35.78 crore as compare to the Sep '25 revenue of ₹ 52.23 crore. This represent the decline of -31.5% The revenue of Archit Organosys Ltd for the Dec '25 is ₹ 39.3 crore as compare to the Sep '25 revenue of ₹ 34.32 crore. This represent the growth of 14.51% The ebitda of Anlon Healthcare Ltd for the Dec '25 is ₹ 12.54 crore as compare to the Sep '25 ebitda of ₹ 13.77 crore. This represent the decline of -8.93% The ebitda of Archit Organosys Ltd for the Dec '25 is ₹ 5.58 crore as compare to the Sep '25 ebitda of ₹ 4.16 crore. This represent the growth of 34.13% The net profit of Anlon Healthcare Ltd changed from ₹ 4.54 crore to ₹ 5.15 crore over 7 quarters. This represents a CAGR of 7.47% The net profit of Archit Organosys Ltd changed from ₹ 1.01 crore to ₹ 2.43 crore over 7 quarters. This represents a CAGR of 65.15% The Dividend Payout of Anlon Healthcare Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Archit Organosys Ltd changed from 14.99 % on March 2021 to 0 % on March 2025 . This represents a CAGR of -100.00% over 5 years .

About Anlon Healthcare Ltd

Anlon Healthcare Limited was originally incorporated as 'Anlon Ventures Private Limited', dated November 19, 2013 issued by the RoC. The Company changed the name from 'Anlon Ventures Private Limited' to 'Anlon Healthcare Private Limited' and a fresh Certificate of Incorporation dated May 27, 2015 was issued by the RoC. The status of the Company was subsequently converted to a Public Limited and the name of the Company was changed to 'Anlon Healthcare Limited' dated September 2, 2024 by the RoC. Anlon Healthcare is engaged in manufacturing of Pharma Intermediates and APIs.
They are one of the few manufacturers of loxoprofen sodium dihydrate in India, a notable API , widely used in treatment of pain/inflammation association with conditions including rheumatoid arthritis, osteoarthritis, lower back pain, frozen shoulder, neck-shoulder-arm syndrome, tooth pain or after surgery, injury or tooth extraction.

About Archit Organosys Ltd

Archit Organosys Limited was originally incorporated on 04th August 1993 as 'Shri Chlochem Limited'.
The Company got the name changed to Archit Organosys Limited from Shri Chlochem Limited effective from 19th May, 2012.
The Company is mainly engaged in the business of manufacturing and trading of various chemical products. Major customers of the Company include several large Indian and International companies who are engaged in the Agrochemical Manufacturing Sector, Pharmaceuticals Manufacturing Sector and Cosmetics Manufacturing Sector.
Company has developed various product like MCA, SMCA, CAC and TCAC. Company is selling their products across Pan India as well as USA, Europe, Latin America, Other Asian Countries and South Africa.
These products are used mainly in pharmaceutical Intermediates like Ibuprofen, Diclofenac, Aceclofenac, Oil field chemicals used for Oil Drilling mainly In CMC manufacturing, Agriculture field product majorly 2,4 D-Acid and many others, surfactants and cosmetic products as well as day to day personal use products, also used in Pigment.

FAQs for the comparison of Anlon Healthcare Ltd and Archit Organosys Ltd

Which company has a larger market capitalization, Anlon Healthcare Ltd or Archit Organosys Ltd?

Market cap of Anlon Healthcare Ltd is 644 Cr while Market cap of Archit Organosys Ltd is 77 Cr

What are the key factors driving the stock performance of Anlon Healthcare Ltd and Archit Organosys Ltd?

The stock performance of Anlon Healthcare Ltd and Archit Organosys Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Anlon Healthcare Ltd and Archit Organosys Ltd?

As of March 23, 2026, the Anlon Healthcare Ltd stock price is INR ₹121.35. On the other hand, Archit Organosys Ltd stock price is INR ₹37.73.

How do dividend payouts of Anlon Healthcare Ltd and Archit Organosys Ltd compare?

To compare the dividend payouts of Anlon Healthcare Ltd and Archit Organosys Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.